Intramuscular Ketorolac at Two Single-Dose Regimens

Summary

The purpose of this study was to evaluate a single 15 mg intramuscular (IM) dose of ketorolac for analgesic non-inferiority versus a single 60 mg IM dose for the treatment of acute MSK pain in a military emergency department (ED) that services Department of Defense (DoD), Department of Veteran Affairs (VA), and foreign military beneficiaries

Timeline

Start

2020-06-27

Primary completion

2020-11-09

Completion

2021-02-04

Drugs

Indications